Education
About Us
Working with TipRanks
Follow Us
Isofol Medical AB (SE:ISOFOL)
:ISOFOL
ISOFOL Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.84 - kr3.82
Previous CloseN/A
Volume134.77K
Average Volume (3M)1.46M
Market Cap
kr242.31M
Enterprise Valuekr208.94M
Total Cash (Recent Filing)kr82.11M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Nov 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding281,107,240
10 Day Avg. Volume566,655
30 Day Avg. Volume1,456,618
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Isofol Medical AB News
ISOFOL FAQ
What was Isofol Medical AB’s price range in the past 12 months?
Isofol Medical AB lowest stock price was kr0.84 and its highest was kr3.82 in the past 12 months.
What is Isofol Medical AB’s market cap?
Isofol Medical AB’s market cap is kr242.31M.
When is Isofol Medical AB’s upcoming earnings report date?
Isofol Medical AB’s upcoming earnings report date is Nov 12, 2025 which is in 81 days.
How were Isofol Medical AB’s earnings last quarter?
Currently, no data Available
Is Isofol Medical AB overvalued?
According to Wall Street analysts Isofol Medical AB’s price is currently Overvalued.
Does Isofol Medical AB pay dividends?
Isofol Medical AB does not currently pay dividends.
What is Isofol Medical AB’s EPS estimate?
Isofol Medical AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Isofol Medical AB have?
Isofol Medical AB has 281,107,240 shares outstanding.
What happened to Isofol Medical AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Isofol Medical AB?
Currently, no hedge funds are holding shares in SE:ISOFOL
Company Description
Isofol Medical AB
Isofol Medical AB (ISOFOL) is a pharmaceutical company focused on developing oncology treatments. Headquartered in Sweden, the company is dedicated to improving the efficacy and safety of standard chemotherapy drugs. Its core product, arfolitixorin, is designed to enhance the effectiveness of folate-based cancer therapies, particularly in colorectal cancer. Isofol Medical aims to advance cancer care through innovative pharmaceutical solutions, addressing unmet medical needs in the oncology sector.
Technical Analysis
Ascelia Pharma AB
―
Guard Therapeutics International AB
―
Immunicum AB
―
Xbrane Biopharma AB
―
Xintela AB
―